Published in Dig Dis Sci on January 01, 1992
Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota. Gut (2001) 2.05
Ten years' experience of screening patients with Barrett's oesophagus in a university teaching hospital. Gut (1997) 1.90
Intestinal metaplasia at the squamocolumnar junction in patients attending for diagnostic gastroscopy. Gut (1997) 1.88
Short segment Barrett's oesophagus: prevalence, diagnosis and associations. Gut (1997) 1.75
Cost effectiveness of detecting Barrett's cancer. Gut (1996) 1.63
Inflammation of the gastro-oesophageal junction (carditis) in patients with symptomatic gastro-oesophageal reflux disease: a prospective study. Gut (1999) 1.48
Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia. Gut (2000) 1.46
Trends in incidence and prevalence of specialized intestinal metaplasia, barrett's esophagus, and adenocarcinoma of the gastroesophageal junction. World J Surg (2003) 1.23
Barrett's esophagus in Japanese patients: its prevalence, form, and elongation. J Gastroenterol (2008) 1.17
Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease? Gut (1998) 1.14
Ethnic differences in the prevalence of endoscopic esophagitis and Barrett's esophagus: the long and short of it all. Dig Dis Sci (2004) 1.04
Clinical significance of p53 mutations in adenocarcinoma of the esophagus and cardia. Ann Surg (2000) 1.02
The impact of an antireflux procedure on intestinal metaplasia of the cardia. Ann Surg (1998) 0.99
Significance of intestinal metaplasia in different areas of esophagus including esophagogastric junction. Dig Dis Sci (1997) 0.97
Use of a novel monoclonal antibody in diagnosis of Barrett's esophagus. Dig Dis Sci (2000) 0.92
Time gated fluorescence spectroscopy in Barrett's oesophagus. Gut (2003) 0.87
Barrett esophagus: perspectives on its diagnosis and management in asian populations. Gastroenterol Hepatol (N Y) (2008) 0.86
Gastroesophageal reflux disease: relationship between clinical and histological features. GOSPE. Gruppo Operativo per lo Studio delle Precancerosi dell'Esofago. Dig Dis Sci (1999) 0.86
Validity of the specialized columnar epithelium as a diagnostic criterion of the short segment Barrett's esophagus. Korean J Intern Med (1998) 0.85
Characteristics of patients with columnar-lined Barrett's esophagus and risk factors for progression to esophageal adenocarcinoma. World J Gastroenterol (2005) 0.85
Role of surveillance in intestinal metaplasia of the esophagus and gastroesophageal junction. World J Surg (2003) 0.85
Barrett's esophagus. Dig Dis Sci (2000) 0.82
Mucin pattern reflects the origin of the adenocarcinoma in Barrett's esophagus: a retrospective clinical and laboratorial study. World J Surg Oncol (2009) 0.81
Cell cycle regulation in patients with intestinal metaplasia at the gastro-oesophageal junction. Mol Pathol (2003) 0.79
The value of traditional upper endoscopy as a diagnostic test for Barrett's esophagus. Gastrointest Endosc (2008) 0.79
Barrett's oesophagus and adenocarcinoma. World J Surg Oncol (2004) 0.76
Cytological screening for Barrett's esophagus using a prototype flexible mesh catheter. Dig Dis Sci (2001) 0.76
Differences in the Characteristics of Barrett's Esophagus and Barrett's Adenocarcinoma between the United States and Japan. ISRN Gastroenterol (2013) 0.75
Short-Segment Barrett's Esophagus and Adenocarcinoma. Gastroenterol Hepatol (N Y) (2006) 0.75
Barrett's oesophagus and development of dysplasia and adenocarcinoma. Gut (1993) 0.75
Prolonged measurement of lower oesophageal sphincter function in patients with intestinal metaplasia at the oesophagogastric junction. Gut (2001) 0.75
Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med (2000) 13.21
Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology (2001) 5.80
Gastric surgery is not a risk for Barrett's esophagus or esophageal adenocarcinoma. Gastroenterology (2001) 1.99
Cholecystectomy in cirrhotic patients: a formidable operation. Am J Surg (1982) 1.90
The importance of hiatal hernia in reflux esophagitis compared with lower esophageal sphincter pressure or smoking. J Clin Gastroenterol (1991) 1.77
Comparing lansoprazole and omeprazole in onset of heartburn relief: results of a randomized, controlled trial in erosive esophagitis patients. Am J Gastroenterol (2001) 1.50
Fecal occult blood screening for colorectal cancer in a Veterans Administration Hospital. Am J Surg (1983) 1.47
AHPBA/AJCC consensus conference on staging of hepatocellular carcinoma: consensus statement. HPB (Oxford) (2003) 1.39
Correlation of inflammatory infiltrate with the enlargement of experimental aortic aneurysms. J Vasc Surg (1992) 1.29
Barrett's oesophagus and colonic tumours. Lancet (1985) 1.28
Reflux symptoms are associated with psychiatric disease. Aliment Pharmacol Ther (2001) 1.17
Spontaneous regression of hepatic pseudotumor. Am J Gastroenterol (1992) 1.17
Is there a link between cervical inlet patch and Barrett's esophagus? Gastrointest Endosc (2001) 1.15
Mutagenic urine in cirrhosis. Lancet (1980) 1.13
Synaptophysin: a novel marker for neurons, certain neuroendocrine cells, and their neoplasms. Hum Pathol (1986) 1.07
Pseudomyxoma peritonei associated with colloid carcinoma of the pancreas. Gastroenterology (1986) 1.05
An immunohistochemical study of benign clear cell ('sugar') tumor of the lung. Arch Pathol Lab Med (1991) 1.05
Inflammatory aspects of experimental aneurysms. Effect of methylprednisolone and cyclosporine. Ann N Y Acad Sci (1996) 1.02
Prevalence of oesophagitis in asthmatics. Gut (1992) 1.00
Neuropathy accompanying IgM lambda monoclonal gammopathy. Acta Neuropathol (1983) 1.00
Allopurinol-induced granulomatous hepatitis with cholangitis and a sarcoid-like reaction. Arch Intern Med (1978) 0.99
Neuroendocrine carcinomas of the gastrointestinal tract. Semin Diagn Pathol (1984) 0.99
Prostaglandins in peptic ulcer disease. An overview of current status and future directions. Drugs (1986) 0.98
Clinical features of duodenal somatostatinomas. Surgery (1993) 0.98
Gastric parietal cell carcinoma--a newly recognized entity: light microscopic and ultrastructural features. Histopathology (1984) 0.96
Primary nodal gastrinomas. Arch Pathol Lab Med (2000) 0.96
Temporal associations between coughing or wheezing and acid reflux in asthmatics. Gut (2001) 0.96
Node-positive duodenal carcinoma is curable. Arch Surg (1997) 0.95
Neuroendocrine carcinomas of the colon. Ultrastructural and biochemical evidence of their secretory function. Am J Surg Pathol (1978) 0.95
Risk factors for erosive reflux esophagitis: a case-control study. Am J Gastroenterol (2001) 0.94
Ultrastructural and biochemical analysis of "undifferentiated" pulmonary carcinomas. Hum Pathol (1978) 0.93
Malignant mesotheliomas. Improved differential diagnosis from lung adenocarcinomas using monoclonal antibodies 44-3A6 and 624A12. Am J Pathol (1986) 0.92
Neuroendocrine carcinomas of the esophagus. Ultrastruct Pathol (1981) 0.92
Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group. Am J Gastroenterol (1996) 0.92
Tissue fixation methods alter the immunohistochemical demonstrability of synaptophysin. Ultrastruct Pathol (1989) 0.91
Malignant gastric neuroendogrinomas. Ultrastructural and biochemical characterization of their secretory activity. Hum Pathol (1977) 0.91
Giant antral ulcer: a rare presentation of eosinophilic gastroenteritis--case report and review of the literature. Am J Gastroenterol (1997) 0.90
Risk factors of oesophagitis in arthritic patients. Eur J Gastroenterol Hepatol (2001) 0.90
Angiomyofibroblastoma of the spermatic cord. Br J Urol (1997) 0.90
Prokinetics in the treatment of gastro-oesophageal reflux disease. International symposium. Paris, France, 5 September 1996. Eur J Gastroenterol Hepatol (1998) 0.89
Parathyroid carcinoma: biochemical and pathologic response to DTIC. Surgery (1984) 0.89
Amphicrine cells, dysplasias, and neoplasias. Cancer (1985) 0.88
Is gastroesophageal reflux a factor in some asthmatics? Am J Gastroenterol (1987) 0.88
Pancreatic carcinoma in brothers. Ann Intern Med (1982) 0.88
"Myeloma lung"--a previously unreported complication of multiple myeloma. Hum Pathol (1983) 0.88
There are no reliable symptoms for erosive oesophagitis and Barrett's oesophagus: endoscopic diagnosis is still essential. Aliment Pharmacol Ther (2002) 0.87
Misoprostol in the treatment of duodenal ulcer. A multicenter double-blind placebo-controlled study. Dig Dis Sci (1985) 0.87
Barrett esophagus-associated small cell carcinoma. Arch Pathol Lab Med (1999) 0.85
Asthma and gastroesophageal reflux. Am J Gastroenterol (2000) 0.85
"Nonfunctioning" islet cell carcinoma of the pancreas. Am Surg (1983) 0.85
Regulation of Lewis lung carcinoma invasion and metastasis by protein kinase A. Int J Cancer (1995) 0.84
Adult nesidioblastosis. An unusual cause of fasting hypoglycemia. Am Surg (1989) 0.84
von Hippel angiomatosis. A light, electron microscopic, and immunoperoxidase characterization. Ophthalmology (1983) 0.83
Multicystic abdominal peritoneal tumor presenting as an enlarging incisional hernia. Ultrastruct Pathol (1985) 0.82
Efficacy of misoprostol (twice daily dosage) in acute healing of duodenal ulcer. A multicenter double-blind controlled trial. Dig Dis Sci (1986) 0.82
Synaptophysin. A new marker for pancreatic neuroendocrine tumors. Am J Surg Pathol (1987) 0.81
CD40L (CD154) expression in human liver allografts during chronic ductopenic rejection. Liver Transpl Surg (1999) 0.81
Walking and chewing reduce postprandial acid reflux. Aliment Pharmacol Ther (2001) 0.81
Adult nesidiodysplasia. Semin Diagn Pathol (1984) 0.80
Effects of radiation on parafollicular C cells of the thyroid gland. Surgery (1983) 0.80
Inguinal hernia is not a sign of colon cancer: results of a prospective screening trial. Aliment Pharmacol Ther (2002) 0.80
Pseudomembranous gastritis: a novel complication of Aspergillus infection in a patient with a bone marrow transplant and graft versus host disease. Arch Pathol Lab Med (2000) 0.80
The APUD cell system and its neoplasms: observations on the significance and limitations of the concept. Surg Clin North Am (1979) 0.79
The induction of esophageal tumors in mice: dose and time dependency. In Vivo (1992) 0.79
The significance of intraepithelial eosinophils in the histologic diagnosis of gastroesophageal reflux. Am J Clin Pathol (1987) 0.78
Experimental study of determinants of aneurysmal expansion of the abdominal aorta. Ann Vasc Surg (1994) 0.78
Antigenic markers of hepatocellular carcinoma. Cancer (1990) 0.78
The value of electron microscopy in diagnostic pathology. Case 13. Ultrastruct Pathol (1981) 0.78
Immunocytochemical localization of keratin in normal, dysplastic and neoplastic cervical epithelium. Gynecol Obstet Invest (1984) 0.78
Barrett's esophagus. The cytology of dysplasia in comparison to benign and malignant lesions. Acta Cytol (1992) 0.78
No association between gallstones and gastroesophageal reflux disease. Am J Gastroenterol (2001) 0.78
Neuroendocrine background of the pathology of the islets of Langerhans. A minireview with particular reference to synaptophysin and chromogranin A as neuroendocrine markers and to the ontogeny of argyrophil insulin immunoreactive cells in the rabbit. Exp Clin Endocrinol (1987) 0.77
Intragraft localization of activated nuclear factor kappaB in recurrent hepatitis C virus disease following liver transplantation. Hepatology (2000) 0.77
Bombesin in human neuroendocrine (NE) neoplasms. Peptides (1985) 0.77
Lansoprazole heals erosive reflux oesophagitis in patients with Barrett's oesophagus. Aliment Pharmacol Ther (1997) 0.77
Transarterial chemoembolization for HCC in patients with extensive liver transplantation waiting times. Angiology (2011) 0.76
Morphologic adaptation following segmental living related intestinal transplantation. Transplant Proc (2002) 0.76
Cystic glucagonoma: A rare variant of an uncommon neuroendocrine pancreas tumor. J Gastrointest Surg (1999) 0.76
Hepatic ischemia/reperfusion injury can be modulated with thymoglobulin induction therapy. Transplant Proc (2005) 0.76
Ranitidine bismuth citrate plus clarithromycin: a dual therapy regimen for patients with duodenal ulcer. Helicobacter (1998) 0.76
Structural analysis in medicine--hiatal hernia, heartburn, Hercules, and the Hydra. J Clin Gastroenterol (1991) 0.75
Fecal occult blood testing: a false sense of security? Surgery (1994) 0.75
Controversies in pathology. Is cirrhosis of the liver a reversible disease? Arch Pathol Lab Med (2000) 0.75
Gut feelings about asthma. The burp and the wheeze. Chest (1991) 0.75
Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin. Am J Gastroenterol (2001) 0.75
Gangrene of the colon associated with essential mixed cryoglobulinemia: case report. Mil Med (1984) 0.75
Prostaglandins and acid peptic disease. Am J Gastroenterol (1986) 0.75
Omeprazole versus placebo in duodenal ulcer healing. The United States experience. Dig Dis Sci (1990) 0.75
Does lead play a role in Paget's disease of bone? A hypothesis. J Lab Clin Med (1992) 0.75
Linitis plastica-like carcinoma of the urinary bladder. Br J Urol (1989) 0.75
Acquired cystic disease in kidneys of patients with chronic renal failure. Artif Organs (1984) 0.75
Liver biopsy: special histologic techniques including immunopathology. Lab Res Methods Biol Med (1983) 0.75
Mucosal morphologic changes of intestinal transplant recipients with severe cholestasis. Transplant Proc (2002) 0.75
A piece of mind. A piece of her heart. JAMA (1988) 0.75
Late development of metastases from retroperitoneal paraganglioma. Ultrastruct Pathol (1984) 0.75